Results 71 to 80 of about 5,525,052 (336)

Evaluation of the quality of multiple-choice questions according to the students’ academic level

open access: yesBMC Medical Education, 2022
Background One of the most important challenges in medical education is the preparation of multiple-choice questions able to discriminate between students with different academic level.
Mercedes Iñarrairaegui   +6 more
doaj   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

Single‐cell DNA methylation profiling: Technologies, computation, and applications in precision oncology

open access: yesMolecular Oncology, EarlyView.
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley   +1 more source

Monotonicity of Power Indices [PDF]

open access: yes, 1998
The paper investigates general properties of power indices, measuring the voting power in committees. Concepts of local and global monotonicity of power indices are introduced. Shapley-Shubik, Banzhaf-Coleman, and Holler-Packel indices are analyzed and it is proved that while Shapley-Shubik index satisfies both local and global monotonicity property ...
openaire   +2 more sources

Computing Classical Power Indices For Large Finite Voting Games. [PDF]

open access: yes
Voting Power Indices enable the analysis of the distribution of power in a legislature or voting body in which different members have different numbers of votes.
Leech, D.
core  

Spatial biology in cancer epigenetics

open access: yesMolecular Oncology, EarlyView.
Spatial epigenomics combines molecular profiling with tissue architecture to reveal how gene regulation is organized within intact tissues. In cancer, these technologies uncover the mechanisms driving tumor heterogeneity and microenvironmental interactions, opening new opportunities for biomarker discovery and precision medicine.
Eva Crespo‐García, Manel Esteller
wiley   +1 more source

Standard Voting Power Indices Work: An Experimental Investigation of Pure Voting Power [PDF]

open access: yes
We evaluate the accuracy of power indices by experimentally measuring the political power embodied in blocks of votes per se. The experiment incorporates several subjects interacting in online chat rooms under supervision.
Ranya SHAHWAN   +2 more
core  

The utility of the voting power approach [PDF]

open access: yes, 2003
This paper argues that the voting power approach is much more general than is portrayed by Albert (“The Voting Power Approach: Measurement without Theory”, European Union Politics, 4:3, 2003) and is therefore capable of generating important insights ...
Leech, Dennis
core  

Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy

open access: yesMolecular Oncology, EarlyView.
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen   +19 more
wiley   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

open access: yesMolecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy